Видео ютуба по тегу Laurus Labs Cdmo

Laurus Labs Q2 Review: Revenue Up By 53% In CDMO Biz; Is FY27 Outlook Better Than FY26?
Laurus Labs Q2 Review: Revenue Up By 53% In CDMO Biz; Is FY27 Outlook Better Than FY26?
Laurus Labs Explained: CDMO Pivot, Margins & Valuation | Is the Laurus Correction an Opportunity?
Laurus Labs Explained: CDMO Pivot, Margins & Valuation | Is the Laurus Correction an Opportunity?
Результаты Laurus Labs за второй квартал превзошли ожидания: рост CDMO, расширение маржи и планы ...
Результаты Laurus Labs за второй квартал превзошли ожидания: рост CDMO, расширение маржи и планы ...
Laurus Labs Q3 FY26 Earnings Conference Call | Concall.in
Laurus Labs Q3 FY26 Earnings Conference Call | Concall.in
Laurus Labs Q3 FY26 Concall: Management on CDMO Momentum and API Recovery
Laurus Labs Q3 FY26 Concall: Management on CDMO Momentum and API Recovery
Laurus Labs: ARV Recovery Gaining Traction; Strong CDMO Growth | Dr Satyanarayana Chava Explains
Laurus Labs: ARV Recovery Gaining Traction; Strong CDMO Growth | Dr Satyanarayana Chava Explains
Laurus Labs & OneSource Specialty Pharma Heads Discuss India's CRDMO Opportunity With Madhu Kela
Laurus Labs & OneSource Specialty Pharma Heads Discuss India's CRDMO Opportunity With Madhu Kela
Laurus Labs Reported Strong Margin Expansion, With Q3 EBITDA Margin At 27% | Dr. Satyanarayana Chava
Laurus Labs Reported Strong Margin Expansion, With Q3 EBITDA Margin At 27% | Dr. Satyanarayana Chava
Our CDMO Business Revenue Is Moving Towards ₹500 Crore Per Quarter: Laurus Labs | CNBC TV18
Our CDMO Business Revenue Is Moving Towards ₹500 Crore Per Quarter: Laurus Labs | CNBC TV18
CRDMO Boom Explained 📈 | Laurus Labs vs Divi’s Laboratories
CRDMO Boom Explained 📈 | Laurus Labs vs Divi’s Laboratories
Laurus Labs Q3FY26 Earnings Call | Laurus Labs Q3FY26 Earnings ConCall | Laurus Labs Ltd
Laurus Labs Q3FY26 Earnings Call | Laurus Labs Q3FY26 Earnings ConCall | Laurus Labs Ltd
'No Plans To List CDMO Biz' Says Laurus Labs Founder As Vertical Aids Revenue Growth Of 31.4% YoY
'No Plans To List CDMO Biz' Says Laurus Labs Founder As Vertical Aids Revenue Growth Of 31.4% YoY
Laurus Labs Q3FY26 Earnings Concall
Laurus Labs Q3FY26 Earnings Concall
Laurus Labs’ Satyanarayana Chava Shares View On CDMO Business
Laurus Labs’ Satyanarayana Chava Shares View On CDMO Business
Laurus Labs Ltd Q3 FY2025-26 Earnings Conference Call
Laurus Labs Ltd Q3 FY2025-26 Earnings Conference Call
Seeing Strong Orders In The CDMO Business: Laurus Labs | CNBC TV18
Seeing Strong Orders In The CDMO Business: Laurus Labs | CNBC TV18
What Makes Indian CDMOs An Attractive Space | Insight | BQ Prime
What Makes Indian CDMOs An Attractive Space | Insight | BQ Prime
LAURUS LABS CDMO Turnaround Story mid Analysis & 1200 Target 6 8 Months
LAURUS LABS CDMO Turnaround Story mid Analysis & 1200 Target 6 8 Months
Laurus Labs Q2 FY25 Earnings Call Summary | CDMO Growth & Industry Trends
Laurus Labs Q2 FY25 Earnings Call Summary | CDMO Growth & Industry Trends
Поэтапное инвестирование 2000 крор рупий совместно с европейским партнером Krka: Laurus Labs | CN...
Поэтапное инвестирование 2000 крор рупий совместно с европейским партнером Krka: Laurus Labs | CN...
Laurus Labs Q2 FY26 Concall: Pharma & CDMO Segments Drive Revenue Recovery
Laurus Labs Q2 FY26 Concall: Pharma & CDMO Segments Drive Revenue Recovery